Calliope Dendrou is a Kennedy Trust for Rheumatology Research Group Leader in Clinical Pathology based at the Kennedy Institute of Rheumatology (KIR). She previously held a Wellcome & Royal Society Sir Henry Dale Fellowship to start her own group in 2017 at the Wellcome Centre for Human Genetics in Oxford, where she was also the Equality, Diversity and Inclusion Champion, before moving to the KIR in 2023.
Calli’s research focuses on investigating shared molecular circuits and cellular mechanisms across tissues and across immune-mediated diseases. Her group uses high-resolution genomic profiling technologies to help elucidate cross-disease pathophysiology, particularly as pathological drivers may evolve over time and may change due to environmental influences and therapeutic intervention. Her research aims to identify ‘hubs’ that may be targeted therapeutically via drug repositioning approaches, with an especial emphasis on cytokine signalling pathways.
She is also the Data Analysis Lead for several large-scale collaborative projects including the Oxford-Janssen Cartography Consortium, and enjoys teaching on the MSc in Genomic Medicine as the Single-cell Omics Module Lead.
